cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsy

Epilepsy is a prevalent neurological disease with a third of patients becoming non-responsive to antiepileptic drugs and developing drug-refractory epilepsy (DRE). Here we report that DRE disease progression is contributed by overactive cyclic GMP-AMP synthase (cGAS), a double-stranded DNA sensor that induces type I interferon (IFN-I) signaling. In human DRE microglia, we observe a robust IFN-I signature and the activation of upstream cGAS-STING signaling. Further, in mouse models of Dravet syndrome, a genetic form of DRE, we observe the activation of the cGAS pathway. We show that microglial cGAS can be activated by DNA released from hyperexcitable neurons. Genetic reduction and pharmacological inhibition of cGAS reduces epileptic phenotypes, glial inflammatory signatures, and neuronal transcriptomic changes, underscoring the therapeutic potential of targeting cGAS for DRE treatment.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-02-02
DOI
https://doi.org/10.64898/2026.01.30.702860
Citations
1
Primary Topic
interferon and immune responses
Type
article
Field-Weighted Citation Impact
24.43
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsy

Subhash C. Sinha, Zhuofan Lei, Benjamin Liechty, Man Ying Wong et al.
1 citations
bioRxiv (Cold Spring Harbor Laboratory)
interferon and immune responses
24.43
article

cGAS-mediated IFN-I signaling contributes to disease progression in drug-refractory epilepsy

Subhash C. Sinha, Zhuofan Lei, Benjamin Liechty, Man Ying Wong, Daphne Zhu, Nagiri Ravi Kumar, Mika P. Cadiz, Sadaf Amin, Y. H. D. Lee, Shiaoching Gong, Balaji Krishnamachary, H LI, H Li, Hao Chen, Li Gan, Kelli Lauderdale, Jorge J Palop, Jingjie Zhu, Pearly Ye, Wenjie Luo, Li Fan, Yige Huang, Maitreyee Bhagwat, Kendra Norman
article en
1 citations

Abstract

Epilepsy is a prevalent neurological disease with a third of patients becoming non-responsive to antiepileptic drugs and developing drug-refractory epilepsy (DRE). Here we report that DRE disease progression is contributed by overactive cyclic GMP-AMP synthase (cGAS), a double-stranded DNA sensor that induces type I interferon (IFN-I) signaling. In human DRE microglia, we observe a robust IFN-I signature and the activation of upstream cGAS-STING signaling. Further, in mouse models of Dravet syndrome, a genetic form of DRE, we observe the activation of the cGAS pathway. We show that microglial cGAS can be activated by DNA released from hyperexcitable neurons. Genetic reduction and pharmacological inhibition of cGAS reduces epileptic phenotypes, glial inflammatory signatures, and neuronal transcriptomic changes, underscoring the therapeutic potential of targeting cGAS for DRE treatment.

bioRxiv (Cold Spring Harbor Laboratory)
University of Maryland, Baltimore (US), Gladstone Institutes (US), NewYork–Presbyterian Hospital (US), Cornell University (US), New York Hospital Queens (US), Presbyterian Hospital (US), MIND Research Institute (US)
Good health and well-being
Openalex Percentile: Top 2%
interferon and immune responses
24.43
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.